Healthcare & Life Science M&A Activity Plummets 1H’22
HIT Consultant
AUGUST 5, 2022
Supply costs are often less significant in the cost structure of PPM companies, and campaigns run by large drug companies in an effort to increase market share for pharmaceuticals coming off patent expiration may generate additional opportunities for PPM companies to achieve higher margins on J-Code drug billing. from $34.61 in CY 2023.
Let's personalize your content